ABM · Abm Industries Inc /De/
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $389.2M | Nine Months Ended July 31, 2026 | — |
| Adjusted net income non-GAAP | $164.8M | Nine Months Ended July 31, 2026 | — |
| Adjusted net income per diluted share non-GAAP | $1.04 | Three Months Ended July 31, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net income per diluted share $0.84
+$0.2 Items impacting comparability, net of taxes
= Adjusted net income per diluted share $1.04
|
|||
| Available liquidity | 605.8M | Q3 FY2026 | — |
| Free cash flow non-GAAP | 199.6M | nine months ended July 31, 2026 | — |
| Organic revenue growth | 2.1% | Q3 FY2026 | — |
| Segment operating margin non-GAAP | 7.7% | Three Months Ended July 31, 2026 | — |
| Segment operating profit non-GAAP | $178.3M | Three Months Ended July 31, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Business Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ABM
this stock
Abm Industries Inc /De/
|
$2.91B | +13.7% | +4.6% | 17.9 | 3.4% |
|
CTAS
Cintas Corp
|
$78.56B | +3.7% | +6.4% | 40.0 | 2.8% |
|
RELX
Relx PLC
|
$58.28B | -17.9% | — | — | 0.4% |
|
TRI
Thomson Reuters Corp /Can/
|
$42.89B | -26.2% | — | — | 2.9% |
|
CPRT
Copart Inc
|
$25.27B | -30.3% | +24.7% | 17.6 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ABM | -3.2% | +3.6% | +21.9% | +3.2% | +13.7% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -2.5% | +3.5% | +9.8% | +3.7% | +1.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.